Ceapro Closes a Loan Agreement with Symrise AG
EDMONTON, ALBERTA -- (Marketwired) -- 12/20/13 -- Ceapro Inc. (TSX VENTURE:CZO) ("Ceapro" or "the Company") is very pleased to announce the signing of a Loan Agreement with its major partner, Symrise, a German-based multinational company.
"This significant financial support from Symrise fully provides Ceapro with the required capital to complete the construction and implementation of the state of the art facility in Edmonton," said Gilles Gagnon, President and CEO of Ceapro. "This loan from Symrise follows the signing earlier this year of a long-term Distribution Agreement between Symrise and Ceapro. We are again delighted and honoured with this recognition and vote of confidence from such a highly respected international player in our industry," he added.
"This Agreement is further evidence of the long-term partnership between Ceapro and Symrise and we look forward to the next steps in joining forces and competencies for the development of new products and new markets," said Dr. Klaus Stanzl, President and CEO, Life Essentials Division, Symrise Ag.
About Ceapro Inc.
Ceapro Inc. is a Canadian growth-stage biotechnology company. Primary business activities relate to the development and commercialization of active ingredients for personal care and cosmetic industries using proprietary technology and natural, renewable resources. To learn more about Ceapro, visit www.ceapro.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Vice President and CFO
Telephone (Edmonton): 780.917.8376
Source: Ceapro Inc.
Released December 20, 2013